Overview

28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

Status:
Terminated

Trial end date:
2010-03-01

Target enrollment:

Participant gender:

Summary

The study will assess the use of paliperidone palmitate compared with oral risperidone in delaying time to relapse in patients recently diagnosed with schizophrenia who are at high risk of relapse.

Phase:

Phase 4

Details

Lead Sponsor:

Ortho-McNeil Janssen Scientific Affairs, LLC

Treatments:

Paliperidone Palmitate
Risperidone